Nina Bhardwaj

Biosketch / Results /

Nina Bhardwaj

Adjunct Professor, Department of Medicine
Adjunct Professor, Department of Pathology

Dir Melanoma Resh Pgm Medical Dir Vac Facility

Contact Info

212/263-5814
Nina.Bhardwaj@nyumc.org

Research Interests

Immunology, Cancer Immunotherapy, HIV, Vaccines, Autoimmunity

Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials
Kohrt, Holbrook E; Tumeh, Paul C; Benson, Don; Bhardwaj, Nina; Brody, Joshua; Formenti, Silvia; Fox, Bernard A; Galon, Jerome; June, Carl H; Kalos, Michael; Kirsch, Ilan; Kleen, Thomas; Kroemer, Guido; Lanier, Lewis; Levy, Ron; Lyerly, H Kim; Maecker, Holden; Marabelle, Aurelien; Melenhorst, Jos; Miller, Jeffrey; Melero, Ignacio; Odunsi, Kunle; Palucka, Karolina; Peoples, George; Ribas, Antoni; Robins, Harlan; Robinson, William; Serafini, Tito; Sondel, Paul; Vivier, Eric; Weber, Jeff; Wolchok, Jedd; Zitvogel, Laurence; Disis, Mary L; Cheever, Martin A. Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials. Journal for immunotherapy of cancer. 2016 ;4:15-15 (2202632)

The effect of ipilimumab on natural killer cells identifies the subset of advanced melanoma patients with clinical response
Da Silva, Ines Esteves Domingues Pires; Gallois, Anne; Lui, Kevin P; Shapiro, Richard L; Pavlick, Anna C; Bhardwaj, Nina; Osman, Iman. The effect of ipilimumab on natural killer cells identifies the subset of advanced melanoma patients with clinical response [Meeting Abstract]. Journal of clinical oncology. 2015 MAY 20;33(15):?-? (1729532)

Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells
Fernandez, Melissa Victoria; Miller, Elizabeth; Krammer, Florian; Gopal, Ramya; Greenbaum, Benjamin D; Bhardwaj, Nina. Ion efflux and influenza infection trigger NLRP3 inflammasome signaling in human dendritic cells. Journal of leukocyte biology. 2015 Nov 16;99(5):723-734 (1848452)

Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High Risk Melanoma
Lubong Sabado, Rachel; Pavlick, Anna; Gnjatic, Sacha; Cruz, Crystal M; Vengco, Isabelita; Hasan, Farah; Spadaccia, Meredith; Darvishian, Farbod; Chiriboga, Luis; Holman, Rose Marie; Escalon, Juliet; Muren, Caroline; Escano, Crystal; Yepes, Ethel; Sharpe, Dunbar; Vasilakos, John P; Rolnitzky, Linda; Goldberg, Judith D; Mandeli, John P; Adams, Sylvia; Jungbluth, Achim A; Pan, Linda; Venhaus, Ralph; Ott, Patrick A; Bhardwaj, Nina. Resiquimod as an Immunologic Adjuvant for NY-ESO-1 Protein Vaccination in Patients with High Risk Melanoma. Cancer immunology research. 2015 Jan 29;3(3):278-287 (1447932)

Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection
Miller, Elizabeth A; Gopal, Ramya; Valdes, Vanessa; Berger, Jeffrey S; Bhardwaj, Nina; O'Brien, Meagan P. Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection. AIDS. 2015 Jul 17;29(11):1287-1296 (1631122)